Classon, M. & Harlow, E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer2, 910–917 (2002). ArticlePubMedCAS Google Scholar
Knudsen, E. S. & Knudsen, K. E. Tailoring to RB: tumour suppressor status and therapeutic response. Nat. Rev. Cancer8, 714–724 (2008). ArticlePubMedPubMed CentralCAS Google Scholar
Kareta, M. S. et al. Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis. Cell Stem Cell16, 39–50 (2015). ArticlePubMedCAS Google Scholar
Ferrari, R. et al. Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection. Cell Host Microbe16, 663–676 (2014). ArticlePubMedPubMed CentralCAS Google Scholar
Avni, D. et al. Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage. Mol. Cell12, 735–746 (2003). ArticlePubMedCAS Google Scholar
Wells, J., Yan, P. S., Cechvala, M., Huang, T. & Farnham, P. J. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase. Oncogene22, 1445–1460 (2003). ArticlePubMedCAS Google Scholar
Cecchini, M. J. & Dick, F. A. The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein. Biochem. J.434, 297–308 (2011). ArticlePubMedCAS Google Scholar
Cecchini, M. J. et al. Loss of the retinoblastoma tumor suppressor correlates with improved outcome in patients with lung adenocarcinoma treated with surgery and chemotherapy. Hum. Pathol.46, 1922–1934 (2015). ArticlePubMedCAS Google Scholar
Bosco, E. E. et al. The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J. Clin. Invest.117, 218–228 (2007). ArticlePubMedCAS Google Scholar
Witkiewicz, A. K. et al. RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer. Clin. Cancer Res.18, 5110–5122 (2012). ArticlePubMedPubMed CentralCAS Google Scholar
Kommoss, S. et al. Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Br. J. Cancer96, 306–313 (2007). ArticlePubMedPubMed CentralCAS Google Scholar
Ludovini, V. et al. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer. Lung Cancer46, 77–85 (2004). ArticlePubMed Google Scholar
Zhao, W. et al. Altered p16(INK4) and RB1 expressions are associated with poor prognosis in patients with nonsmall cell lung cancer. J. Oncol.2012, 957437 (2012). ArticlePubMedPubMed CentralCAS Google Scholar
Garsed, D. W. et al. Homologous recombination DNA repair pathway disruption and retinoblastoma protein loss are associated with exceptional survival in high-grade serous ovarian cancer. Clin. Cancer Res.24, 569–580 (2017). ArticlePubMedCAS Google Scholar
Knudsen, E. S. et al. Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression. J. Natl Cancer Inst.104, 1825–1836 (2012). ArticlePubMedPubMed CentralCAS Google Scholar
Sharma, A. et al. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J. Clin. Invest.120, 4478–4492 (2010). ArticlePubMedPubMed CentralCAS Google Scholar
McNair, C. et al. Differential impact of RB status on E2F1 reprogramming in human cancer. J. Clin. Invest.128, 341–358 (2017). ArticlePubMedPubMed Central Google Scholar
Kitajima, S. & Takahashi, C. Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation. Cancer Sci.108, 1726–1731 (2017). ArticlePubMedPubMed CentralCAS Google Scholar
Nicolay, B. N. & Dyson, N. J. The multiple connections between pRB and cell metabolism. Curr. Opin. Cell Biol.25, 735–740 (2013). ArticlePubMedCAS Google Scholar
Ciavarra, G. & Zacksenhaus, E. Direct and indirect effects of the pRb tumor suppressor on autophagy. Autophagy7, 544–546 (2011). ArticlePubMedCAS Google Scholar
Indovina, P., Pentimalli, F., Casini, N., Vocca, I. & Giordano, A. RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy. Oncotarget6, 17873–17890 (2015). ArticlePubMedPubMed Central Google Scholar
Blanchet, E. et al. E2F transcription factor-1 regulates oxidative metabolism. Nat. Cell Biol.13, 1146–1152 (2011). ArticlePubMedCAS Google Scholar
Jones, R. A. et al. RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. J. Clin. Invest.126, 3739–3757 (2016). ArticlePubMedPubMed Central Google Scholar
Lee, W. H. et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature329, 642–645 (1987). ArticlePubMedCAS Google Scholar
Adams, P. D. et al. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol. Cell. Biol.19, 1068–1080 (1999). ArticlePubMedPubMed CentralCAS Google Scholar
Carr, S. M., Munro, S., Kessler, B., Oppermann, U. & La Thangue, N. B. Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J.30, 317–327 (2011). ArticlePubMedCAS Google Scholar
Munro, S., Khaire, N., Inche, A., Carr, S. & La Thangue, N. B. Lysine methylation regulates the pRb tumour suppressor protein. Oncogene29, 2357–2367 (2010). ArticlePubMedCAS Google Scholar
Chan, H. M., Krstic-Demonacos, M., Smith, L., Demonacos, C. & La Thangue, N. B. Acetylation control of the retinoblastoma tumour-suppressor protein. Nat. Genet.3, 667–674 (2001). CAS Google Scholar
Hirschi, A. et al. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat. Struct. Mol. Biol.17, 1051–1057 (2010). ArticlePubMedPubMed CentralCAS Google Scholar
Julian, L. M., Palander, O., Seifried, L. A., Foster, J. E. & Dick, F. A. Characterization of an E2F1-specific binding domain in pRB and its implications for apoptotic regulation. Oncogene27, 1572–1579 (2008). ArticlePubMedCAS Google Scholar
Rubin, S. M., Gall, A. L., Zheng, N. & Pavletich, N. P. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell123, 1093–1106 (2005). ArticlePubMedCAS Google Scholar
Calbo, J. et al. G1 cyclin/cyclin-dependent kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J. Biol. Chem.277, 50263–50274 (2002). ArticlePubMedCAS Google Scholar
Liban, T. J. et al. Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family. Proc. Natl Acad. Sci. USA114, 4942–4947 (2017). ArticlePubMedPubMed CentralCAS Google Scholar
Cecchini, M. J. et al. A retinoblastoma allele that is mutated at its common E2F interaction site inhibits cell proliferation in gene targeted mice. Mol. Cell. Biol.34, 2029–2045 (2014). ArticlePubMedPubMed CentralCAS Google Scholar
Dick, F. A. & Dyson, N. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol. Cell12, 639–649 (2003). ArticlePubMedCAS Google Scholar
Gubern, A. et al. The N-terminal phosphorylation of RB by p38 bypasses its inactivation by CDKs and prevents proliferation in cancer cells. Mol. Cell64, 25–36 (2016). ArticlePubMedCAS Google Scholar
Julian, L. M. et al. Opposing regulation of Sox2 by cell-cycle effectors E2f3a and E2f3b in neural stem cells. Cell Stem Cell12, 440–452 (2013). ArticlePubMedCAS Google Scholar
Alabert, C. & Groth, A. Chromatin replication and epigenome maintenance. Nat. Rev. Mol. Cell Biol.13, 153–167 (2012). ArticlePubMedCAS Google Scholar
Cook, R. et al. Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous end-joining. Cell Rep10, 2006–2018 (2015). ArticlePubMedPubMed CentralCAS Google Scholar
Velez-Cruz, R. et al. RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1. Genes Dev.30, 2500–2512 (2016). ArticlePubMedPubMed CentralCAS Google Scholar
Coschi, C. et al. Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidy. Cancer Discov.4, 840–853 (2014). ArticlePubMedCAS Google Scholar
Montoya-Durango, D. E. et al. Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat. Res.665, 20–28 (2009). ArticlePubMedPubMed CentralCAS Google Scholar
Chen, J. et al. E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks. Cell Cycle10, 1287–1294 (2011). ArticlePubMedPubMed CentralCAS Google Scholar
Carnevale, J., Palander, O., Seifried, L. A. & Dick, F. A. DNA damage signals through differentially modified E2F1 molecules to induce apoptosis. Mol. Cell. Biol.32, 900–912 (2012). ArticlePubMedPubMed CentralCAS Google Scholar
Chong, J. L. et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature462, 930–934 (2009). ArticlePubMedPubMed CentralCAS Google Scholar
Yamasaki, L. et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell85, 537–548 (1996). ArticlePubMedCAS Google Scholar
Chen, H. Z., Tsai, S. Y. & Leone, G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer9, 785–797 (2009). ArticlePubMedPubMed CentralCAS Google Scholar
Biedermann, S. et al. The retinoblastoma homolog RBR1 mediates localization of the repair protein RAD51 to DNA lesions in Arabidopsis. EMBO J.36, 1279–1297 (2017). ArticlePubMedPubMed CentralCAS Google Scholar
Horvath, B. M. et al. Arabidopsis RETINOBLASTOMA RELATED directly regulates DNA damage responses through functions beyond cell cycle control. EMBO J.36, 1261–1278 (2017). ArticlePubMedPubMed CentralCAS Google Scholar
Montoya-Durango, D. E. et al. LINE-1 silencing by retinoblastoma proteins is effected through the nucleosomal and remodeling deacetylase multiprotein complex. BMC Cancer16, 38 (2016). ArticlePubMedPubMed CentralCAS Google Scholar
Manning, A. L. et al. Suppression of genome instability in pRB-deficient cells by enhancement of chromosome cohesion. Mol. Cell53, 993–1004 (2014). ArticlePubMedPubMed CentralCAS Google Scholar
Gonzalo, S. et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat. Cell Biol.7, 420–428 (2005). ArticlePubMedCAS Google Scholar
Longworth, M. S., Herr, A., Ji, J. Y. & Dyson, N. J. RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3. Genes Dev.22, 1011–1024 (2008). ArticlePubMedPubMed CentralCAS Google Scholar
Woodward, J. et al. Condensin II mutation causes T-cell lymphoma through tissue-specific genome instability. Genes Dev.30, 2173–2186 (2016). ArticlePubMedPubMed CentralCAS Google Scholar
Lukas, J., Lukas, C. & Bartek, J. More than just a focus: the chromatin response to DNA damage and its role in genome integrity maintenance. Nat. Cell Biol.13, 1161–1169 (2011). ArticlePubMedCAS Google Scholar
Mankouri, H. W., Huttner, D. & Hickson, I. D. How unfinished business from S-phase affects mitosis and beyond. EMBO J.32, 2661–2671 (2013). ArticlePubMedPubMed CentralCAS Google Scholar
Munro, S. et al. Linker histone H1.2 directs genome-wide chromatin association of the retinoblastoma tumor suppressor protein and facilitates its function. Cell Rep19, 2193–2201 (2017). ArticlePubMedPubMed CentralCAS Google Scholar
Zheng, L., Flesken-Nikitin, A., Chen, P. L. & Lee, W. H. Deficiency of Retinoblastoma gene in mouse embryonic stem cells leads to genetic instability. Cancer Res.62, 2498–2502 (2002). PubMedCAS Google Scholar
Coschi, C. H. et al. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev.24, 1351–1363 (2010). ArticlePubMedPubMed CentralCAS Google Scholar
Conklin, J. F., Baker, J. & Sage, J. The RB family is required for the self-renewal and survival of human embryonic stem cells. Nat. Commun.3, 1244 (2012). ArticlePubMedCAS Google Scholar
Schvartzman, J. M., Sotillo, R. & Benezra, R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat. Rev. Cancer10, 102–115 (2010). ArticlePubMedPubMed CentralCAS Google Scholar
Sharma, A. et al. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells. Cancer Res.67, 6192–6203 (2007). ArticlePubMedPubMed CentralCAS Google Scholar
Varma, H. & Conrad, S. E. Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain. Oncogene19, 4746–4753 (2000). ArticlePubMedCAS Google Scholar
Mayhew, C. N. et al. Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents. Oncogene23, 4107–4120 (2004). ArticlePubMedCAS Google Scholar
Zagorski, W. A., Knudsen, E. S. & Reed, M. F. Retinoblastoma deficiency increases chemosensitivity in lung cancer. Cancer Res.67, 8264–8273 (2007). ArticlePubMedCAS Google Scholar
Bourgo, R. J. et al. RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control. Mol. Cell43, 663–672 (2011). ArticlePubMedPubMed CentralCAS Google Scholar
Xiao, H. & Goodrich, D. W. The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes. Oncogene24, 8105–8113 (2005). ArticlePubMedPubMed CentralCAS Google Scholar
The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature511, 543–550 (2014). ArticlePubMed CentralCAS Google Scholar
Branzei, D. & Foiani, M. Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol.9, 297–308 (2008). ArticlePubMedCAS Google Scholar
Sherr, C. J., Beach, D. & Shapiro, G. I. Targeting CDK4 and CDK6: from discovery to therapy. Cancer Discov.6, 353–367 (2016). ArticlePubMedCAS Google Scholar
Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. Tumor-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature375, 506–510 (1995). ArticlePubMedCAS Google Scholar
Lukas, J. et al. Retinoblastoma-protein-dependent inhibition by the tumor-suppressor p16. Nature375, 503–506 (1995). ArticlePubMedCAS Google Scholar
Bruce, J. L., Hurford, R. K. J., Classon, M., Koh, J. & Dyson, N. Requirements for cell cycle arrest by p16INK4a. Mol. Cell6, 737–742 (2000). ArticlePubMedCAS Google Scholar
Watson, P. A., Arora, V. K. & Sawyers, C. L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer15, 701–711 (2015). ArticlePubMedPubMed CentralCAS Google Scholar
Tran, C. et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science324, 787–790 (2009). ArticlePubMedPubMed CentralCAS Google Scholar
Rickman, D. S., Beltran, H., Demichelis, F. & Rubin, M. A. Biology and evolution of poorly differentiated neuroendocrine tumors. Nat. Med.23, 1–10 (2017). ArticlePubMedCAS Google Scholar
Bluemn, E. G. et al. Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell32, 474–489 (2017). ArticlePubMedCASPubMed Central Google Scholar
The Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell163, 1011–1025 (2015). ArticlePubMed CentralCAS Google Scholar
Mu, P. et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science355, 84–88 (2017). ArticlePubMedPubMed CentralCAS Google Scholar
Ku, S. Y. et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science355, 78–83 (2017). ArticlePubMedPubMed CentralCAS Google Scholar
Wang, S. et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell4, 209–221 (2003). ArticlePubMedCAS Google Scholar
Zhou, Z. et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res.66, 7889–7898 (2006). ArticlePubMedCAS Google Scholar
Maddison, L. A., Sutherland, B. W., Barrios, R. J. & Greenberg, N. M. Conditional deletion of Rb causes early stage prostate cancer. Cancer Res.64, 6018–6025 (2004). ArticlePubMedCAS Google Scholar
Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med.350, 2129–2139 (2004). ArticlePubMedCAS Google Scholar
Kobayashi, S. et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N. Engl. J. Med.352, 786–792 (2005). ArticlePubMedCAS Google Scholar
Yun, C. H. et al. Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell11, 217–227 (2007). ArticlePubMedPubMed CentralCAS Google Scholar
Pirker, R. Third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer. Curr. Opin. Oncol.28, 115–121 (2016). ArticlePubMedCAS Google Scholar
Sequist, L. V. et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci. Transl Med.3, 75ra26 (2011). ArticlePubMedPubMed Central Google Scholar
Oser, M. G., Niederst, M. J., Sequist, L. V. & Engelman, J. A. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol.16, e165–e172 (2015). ArticlePubMedPubMed CentralCAS Google Scholar
Niederst, M. J. et al. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer. Nat. Commun.6, 6377 (2015). ArticlePubMedCAS Google Scholar
Rothenberg, S. M. et al. Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways. eLife4, e06132 (2015). ArticlePubMed CentralCAS Google Scholar
Ting, D. T. et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science331, 593–596 (2011). ArticlePubMedPubMed CentralCAS Google Scholar
Liu, Y. et al. Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell4, 336–347 (2009). ArticlePubMedPubMed CentralCAS Google Scholar
Akamatsu, S. et al. The placental gene PEG10 promotes progression of neuroendocrine prostate cancer. Cell Rep.12, 922–936 (2015). ArticlePubMedCAS Google Scholar
Herrera-Merchan, A. et al. Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease. Nat. Commun.3, 623 (2012). ArticlePubMedCAS Google Scholar
Gonzalez-Vasconcellos, I. et al. Rb1 haploinsufficiency promotes telomere attrition and radiation-induced genomic instability. Cancer Res.73, 4247–4255 (2013). ArticlePubMedCAS Google Scholar
Araki, K., Kawauchi, K., Hirata, H., Yamamoto, M. & Taya, Y. Cytoplasmic translocation of the retinoblastoma protein disrupts sarcomeric organization. eLife2, e01228 (2013). ArticlePubMedPubMed CentralCAS Google Scholar
The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature487, 330–337 (2012). ArticleCAS Google Scholar